Swiss Visio Retina Research Center
@swiss_visio_retina_research_center
Lausannehttps://www.swissmedical.net/en/swiss-visio/centres/research/retina Hospitals and Health CareOverview
About Swiss Visio Retina Research Center
The retina research centre is active in the field of retinal diseases, such as age-related macular degeneration (AMD), diabetic retinopathies, retinal vascular anomalies and cancer-associated retinopathies.
The research carried out at the Swiss Visio Retina Research Center is helping to expand our knowledge of retinal pathologies, contribute to the development of new therapeutic approaches and optimise current treatments.
The multidisciplinary team consists of 17 qualified members of staff, lead by PD Dr méd. Aude Ambresin, founder and head of the research centre and principal investigator.
Our areas of expertise are
- Age-related macular degeneration (AMD)
- Diabetic retinopathy
- Retinal venous and arterial occlusions
- Retinopathies associated with cancer
- Retinal dystrophies
Research activities began in 2019 and the research centre was recognised in 2022. The Swiss Visio Retina Research Center (SVRRC) has been a member of the European Vision Clinical Research network (EVICR.net) since June 2022 (clinical site no. 136). Research activities are conducted in compliance with the high standards of quality and excellence set out in the ICH Good Clinical Practice Guidelines.
The research carried out at the Swiss Visio Retina Research Center is helping to expand our knowledge of retinal pathologies, contribute to the development of new therapeutic approaches and optimise current treatments.
The multidisciplinary team consists of 17 qualified members of staff, lead by PD Dr méd. Aude Ambresin, founder and head of the research centre and principal investigator.
Our areas of expertise are
- Age-related macular degeneration (AMD)
- Diabetic retinopathy
- Retinal venous and arterial occlusions
- Retinopathies associated with cancer
- Retinal dystrophies
Research activities began in 2019 and the research centre was recognised in 2022. The Swiss Visio Retina Research Center (SVRRC) has been a member of the European Vision Clinical Research network (EVICR.net) since June 2022 (clinical site no. 136). Research activities are conducted in compliance with the high standards of quality and excellence set out in the ICH Good Clinical Practice Guidelines.